| Term 
 | Definition 
 
        | opioid receptor antagonist used for rapid detox for heroin
 used to reduce the reward of alcohol
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | relapse prevention for alcoholics blocks acetaldehyde dehydrogenase
 results in flushing HA, N/V, dysphoria
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | benzo used for alcohol detox |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiseizure used for alcohol detox |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | opioid receptor agonist, used for heroin addiction, transfer dependence to methadone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | atypical antidepressant stabilize dopamine levels following tobacco withdrawal
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nicotinic receptor partial agonist reduce dopamine elevation (reduce reward for smoking )
 |  | 
        |  | 
        
        | Term 
 
        | clozapine, quetiapine, olanzapine |  | Definition 
 
        | 2nd generation MOA: blocks D2 receptor, blocks serotonin receptors
 effects: positive, negative, & cognitive sx
 |  | 
        |  | 
        
        | Term 
 
        | haloperidol, fluphenaxine, chlorpromazine |  | Definition 
 
        | 1st generation MOA: D2 receptor antagonists
 effects: positive sx
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOB selective inhibitors clinical use: monotherapy or in comno w/ L-DOPA, may slow progression of parkinsons
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | muscarinic antagonist clinical uses: useful in tx of tremors
 use limited by bad ADRs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 like receptor agonist clincial use: used as early monotherapy or adjunctive therapy w/ LDOPA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | glu receptor antagonist MOA: blocks both indirect & direct pahtways
 clincial use: reduces tremor in early dz, reduce LDOPA induced dyskinesias
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | crosses BBB, effective in reducing all sx pf parkinsons, low PO bioavailability, converted to dopa in periphery, degraded by COMT |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | given w/ LDOPA, blocks conversion to dopamine in periphery & brain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | administered w/ LDOPA to stop COMT degradation, prolongs effect of LDOPA, useful against on/off syndrome, mall allow reduction in dose of levodopa |  | 
        |  |